Comparison of Outcomes of Transfemoral Aortic Valve Implantation in Patients <90 With Those >90 Years of Age

• Published in: The American journal of cardiology 2018-06, Vol.121 (12), p.1581-1586
• Main Authors: Vendrik, Jeroen, van Mourik, Martijn S., van Kesteren, Floortje, Henstra, Marieke J., Piek, Jan J., Henriques, Jose P.S., Wykrzykowska, Joanna J., de Winter, Robbert J., Vis, M. Marije, Koch, Karel T., Baan, Jan
• Format: Article
• Language: English
• Subjects: Age; Age Factors; Aged; Aged, 80 and over; Aortic valve; Aortic Valve Insufficiency - epidemiology; Aortic Valve Stenosis - surgery; Bleeding; Complications; Decision making; Female; Frailty; Geriatrics; Hospital Mortality; Hospitals; Humans; Implantation; Logistic Models; Male; Medical personnel; Mortality; Multivariate Analysis; Odds Ratio; Older people; Patients; Population; Postoperative Complications - epidemiology; Postoperative Hemorrhage - epidemiology; Proportional Hazards Models; Prostheses; Regression analysis; Regurgitation; Risk factors; Stroke; Stroke - epidemiology; Success; Survival; Thorax; Transcatheter Aortic Valve Replacement; Transplants & implants; Treatment Outcome
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2018.02.056

In patients who underwent transcatheter aortic valve implantation (TAVI), postoperative mortality risk is commonly assessed with risk scores such as the Society of Thoracic Surgeons—Postoperative Risk of Mortality (STS-PROM) and EuroSCORE II, in which age plays a dominant role. However, we reason that in the naturally selected oldest-old patients (nonagenarians), this may not be completely justified and that therefore age should play a minor role in decision-making. The objective of this study was to compare procedural outcome and mid-term mortality of transfemoral (TF)-TAVI patients aged ≥90 years with patients aged